Minnesota Legislature
Office of the Revisor of Statutes
Minnesota Administrative Rules
CHAPTER 4606, CANCER SURVEILLANCE SYSTEM
DEPARTMENT OF HEALTH
| Part | Title |
|---|---|
| 4606.3300 | PURPOSE. |
| 4606.3301 | SCOPE. |
| 4606.3302 | DEFINITIONS. |
| 4606.3303 | COMPREHENSIVE REPORTS OF CANCER. |
| 4606.3304 | REPORTS. |
| 4606.3305 | DATA SUBMISSION. |
| 4606.3306 | PHYSICIAN CONSENT. |
| 4606.3307 | AUTHORIZED RESEARCH. |
| 4606.3308 | CONTRACTS. |
| 4606.3309 | CHARGES FOR DATA. |
4606.3300 PURPOSE.
The purpose of parts 4606.3300 to 4606.3309 is to establish a process and assign responsibility for:
History:
13 SR 528; 36 SR 615
Published Electronically:
November 30, 2011
4606.3301 SCOPE.
Parts 4606.3300 to 4606.3309 apply generally to the diagnosis of, reporting of, and epidemiologic studies of cancer; and scientific research on the treatment and prevention of cancer.
History:
13 SR 528
Published Electronically:
May 12, 1997
4606.3302 DEFINITIONS.
Subpart 1.
Abstract.
"Abstract" means an electronic record, in a format specified by the commissioner, which contains the information required in part 4606.3304.
Subp. 2.
Attending physician.
"Attending physician" means the physician who provides primary clinical care for the cancer case.
Subp. 3a.
Cancer registry.
"Cancer registry" means a collection of cancer data on patients that is maintained as an identified repository of such data for or within any hospital, medical clinic, or centralized institution.
Subp. 4.
Case.
"Case" means any Minnesota resident, living or deceased, having a cancer diagnosed by a physician or dentist.
Subp. 5.
Case report.
"Case report" means a complete report of a diagnosis of cancer, which has been made by a physician or dentist. At a minimum, this shall consist of source documents that contain all or as much as is known of the information required in part 4606.3304.
Subp. 6.
Commissioner.
"Commissioner" means the state commissioner of health, or the commissioner's authorized officers, or employees.
Subp. 7.
Demographic form.
"Demographic form" means the front page of a hospital medical record, the hospital business office form, or the pathology specimen submission slip that contains the demographic information required in part 4606.3304 for cases.
Subp. 8.
Dentist.
"Dentist" means any person who is licensed by the Minnesota Board of Dentistry to practice dentistry.
Subp. 10.
Epidemiologic studies.
"Epidemiologic studies" means the compilation of data on health and disease, its scientific analysis to determine the distribution and causes of health problems in populations, and the application of this study to the control of health problems.
Subp. 11.
Hospital.
"Hospital" means any institution licensed as such by the commissioner under Minnesota Statutes, section 144.50.
Subp. 12.
Medical clinic.
"Medical clinic" means any institution staffed by one or more physicians where diseases of human beings are diagnosed.
Subp. 13.
Medical laboratory or pathology laboratory.
"Medical laboratory" or "pathology laboratory" means any facility that reports the results of examinations of organ tissue, cells, or blood specimens from the human body for cancer to physicians who use the reports for purposes of diagnosis or patient care.
Subp. 14.
Minnesota resident.
"Minnesota resident" means a person who provides a permanent address within the borders of the state at the time of cancer diagnosis. In the case of minors, residency shall be determined as that of the parent or legal guardian. This does not mean that Minnesota is the person's legal residence or voting residence.
Subp. 15.
Physician.
"Physician" means a person who is licensed by the Minnesota Board of Medical Practice to practice medicine.
Subp. 16.
Reporting entity.
"Reporting entity" means the individual or operational unit within an institution such as a medical laboratory, hospital, clinic, or cancer registry, designated by the institution to submit case reports required by parts 4606.3300 to 4606.3309.
History:
13 SR 528; L 1991 c 106 s 6; 21 SR 1406; 36 SR 615
Published Electronically:
November 30, 2011
4606.3303 COMPREHENSIVE REPORTS OF CANCER.
Subpart 1.
Cancer registries.
Cancer registries shall forward by first class mail, by messenger, or by electronic means, case reports to the commissioner within 15 working days of the date the patient's record in the cancer registry was completed.
Subp. 2.
Medical laboratories.
Medical laboratories shall forward by first class mail, by messenger, or by electronic means, case reports to the commissioner for all cases of cancer within 15 working days of the date of diagnosis.
Subp. 3.
Hospitals and medical clinics.
Hospitals and medical clinics shall forward by first class mail, by messenger, or by electronic means, case reports to the commissioner for all cases of cancer diagnosed in the institution within 15 working days of the date of diagnosis.
Subp. 4.
Physicians and dentists.
A.
Physicians and dentists who diagnose cancer in humans shall forward by first class mail, by messenger, or by electronic means, case reports to the commissioner within 15 working days of the date of diagnosis.
B.
A physician or dentist is exempted from item A if the physician or dentist (i) is working within a hospital, medical clinic, or medical laboratory required to report by this part, (ii) knows the case was admitted to a hospital required to report by this part, or (iii) has received, from a medical laboratory required to report by this part, a written report indicating the presence of cancer in the case.
Subp. 5.
Designating a reporting entity.
Alternatively, cancer registries, medical laboratories, hospitals, medical clinics, or any combination of these within or as part of an institution, may notify the commissioner of the identity of a reporting entity to report on behalf of the institution and as such shall meet the requirements of cancer reporting under subparts 1 to 4.
History:
13 SR 528; 36 SR 615
Published Electronically:
November 30, 2011
4606.3304 REPORTS.
Subpart 1.
Case information.
Reports of case information that are required in part 4606.3303 must consist of source documents and contain as much of the following information as is known:
Subp. 1a.
Data items.
The commissioner shall, at least once per year and by publication in the State Register and electronic notice on the Minnesota Cancer Surveillance System Web site, provide a list of the data items to be reported under part 4606.3303, subpart 1, and specify the format to be used for electronic reports. The list will be revised according to national cancer reporting standards.
Subp. 1b.
Reporting standards.
The following guides and standards for reporting the information required in subparts 1 and 1a are incorporated by reference and are available through the Minitex interlibrary loan system. They are also available electronically as specified in items A and D.
A.
Standards for Cancer Registries: Volume II, Data Standards and Data Dictionary, Fourteenth Edition Record Layout Version 12 (2010), and subsequent editions; and Volume V, Electronic Pathology Reporting Standards, Version 3.0 (2009) and subsequent editions; North American Association of Central Cancer Registries (NAACCR), Springfield, Illinois. NAACCR reporting standards are updated frequently and are published electronically at www.naaccr.org.
B.
Summary Staging Guide, Cancer Surveillance Epidemiology and End Results Reporting, SEER Program (April 1977, reprinted July 1986), published by the National Institutes of Health (NIH), Public Health Service, U.S. Department of Health and Human Services, NIH publication number 86-2313 (cancers diagnosed before 2001). The Summary Staging Guide is not subject to frequent change.
C.
SEER Summary Staging Manual - 2000 (July 2001), published by the NIH, Public Health Service, U.S. Department of Health and Human Services, NIH publication number 01-4969 (cancers diagnosed in 2001 through 2003). The SEER Summary Staging Manual is not subject to frequent change.
D.
Collaborative Staging Manual and Coding Instructions version 1.0 and subsequent editions, published by the NIH, Public Health Service, U.S. Department of Health and Human Services, NIH publication number 04-5496 (cancers diagnosed in 2004 and later). The Collaborative Staging Manual is subject to frequent change and is published electronically at www.cancerstaging.org/cstage/index.html.
E.
Data Acquisition Manual (revised edition September 1994), published by the Commission on Cancer, American College of Surgeons (cancers diagnosed in 1995). The manual is not subject to frequent change.
F.
Standards of the Commission on Cancer, Volume II: Registry Operations and Data Standards (ROADS) (1996 and 1998), published by the Commission on Cancer, American College of Surgeons (cancers diagnosed in 1996 through 2002). The manual is not subject to frequent change.
G.
Facility Oncology Registry Data Standards (FORDS) (2002 and subsequent editions), published by the Commission on Cancer, American College of Surgeons (cancers diagnosed in 2003 and later). The standards of the Commission on Cancer are changed as often as every year.
H.
Manual for Staging of Cancer (4th edition 1992 and subsequent editions), American Joint Commission on Cancer (AJCC), published by J.B. Lippincott Company. The AJCC manual is not subject to frequent change.
I.
SEER Program Coding and Staging Manual 2007; Johnson CH, Adamo M (eds.), National Cancer Institute, NIH publication number 07-5581, Bethesda, MD 2007. The SEER manual is not subject to frequent change.
Subp. 2.
Abstracts.
Alternatively, reports of case information that are required in part 4606.3303 may consist of completed electronic abstracts and must contain the information required in subpart 1.
Subp. 3.
Occupational data.
Hospitals, medical clinics, and physicians shall, upon request of the commissioner, report as much information as is known concerning the occupational history of cancer cases. The commissioner shall by publication in the State Register request reports of such information when the following conditions exist:
A.
epidemiologic surveillance and studies based on this information will assist in identifying cancer risks in certain occupational groups; and
B.
there is a specific, planned mechanism for the surveillance and epidemiologic study of the cancer related to the occupational group.
History:
13 SR 528; 21 SR 1406; 36 SR 615
Published Electronically:
November 30, 2011
4606.3305 DATA SUBMISSION.
Subpart 1.
Completeness.
Every case report shall include, at a minimum, legible source documents or completed abstracts that must contain the data required in part 4606.3304. Electronic abstracts must be submitted in the format required by the commissioner.
Subp. 2.
Missing information.
The reporting entity or individual shall, within five working days of notification by the commissioner, supply all missing information, if known, or clarify information submitted in any report required in parts 4606.3303 and 4606.3304.
Subp. 3.
Inspection.
For the purpose of assuring the quality and completeness of individual cancer case reports, each reporting entity or individual shall allow the commissioner to inspect the demographic portions of a patient's medical record or medical records related to the diagnosis and treatment of cancer as are necessary to verify the accuracy and completeness of the cancer diagnostic and treatment information and demographic data.
History:
13 SR 528; 21 SR 1406; 36 SR 615
Published Electronically:
November 30, 2011
4606.3306 PHYSICIAN CONSENT.
Subpart 1.
Attempt to obtain consent.
When undertaking epidemiologic studies, the commissioner shall attempt to locate and obtain the consent of the attending physician as identified in the case report before approaching any case named in a report or a personal representative of a deceased case as defined in Minnesota Statutes, section 13.10, subdivision 1, paragraph (c).
Subp. 2.
Approach without consent.
The commissioner may approach a case named in a report or a personal representative of a deceased case as defined in Minnesota Statutes, section 13.10, subdivision 1, paragraph (c), without the consent of the attending physician as identified in the case report in order to conduct epidemiologic investigations if the attending physician is deceased, is no longer licensed in the state, is no longer practicing, cannot otherwise be located, or is no longer caring for the case and is unable to identify the case's current attending physician.
History:
13 SR 528; 36 SR 615
Published Electronically:
November 30, 2011
4606.3307 AUTHORIZED RESEARCH.
Subpart 1.
Criteria.
The commissioner of health may enter into contracts to conduct research, using data collected pursuant to parts 4606.3300 to 4606.3309, with public and private research agencies or with individuals who satisfy all of the following criteria:
A.
the research proposed to be conducted will assist in improving the diagnosis, treatment, or prevention of cancer and the public health;
B.
there is documented evidence that the principal investigator for the research proposed is qualified:
(1)
by having attained the degree of medical doctor, doctor of dental surgery, doctor of science, doctor of philosophy, or equivalent degree from an accredited college or university; and
(2)
by specific academic graduate level training in epidemiology, biomedical research or biometry, or documented evidence of biomedical or related medical research experience; and
C.
there is a written protocol which includes but is not limited to a complete description of:
(3)
the specific methodologies, including data required from the commissioner, to be used in conducting the research and testing of scientific hypotheses;
(5)
the period of time during which the proposed research will be conducted and when a final report will be completed;
(7)
the methods to be used to assure that privacy of data is maintained in accordance with state law, and that access to private, nonpublic data is limited to those authorized by the commissioner to have access.
Subp. 2.
Release of information.
Under no circumstances will researchers be provided access to personal identifiers that would allow contact of a patient without attempting to obtain physician consent as described in part 4606.3306. The following personal identifiers will not be released:
F.
social security number.
No researcher operating under contractual agreement with the commissioner as described in subpart 1 shall release any personal identifier, mark, or description obtained during an investigation that could be used for identification of an institution, a physician, or an individual who is or was the subject of a case report required in part 4606.3303.
Subp. 3.
Evaluation of proposals.
The commissioner shall evaluate proposals based upon the criteria in items A to E.
A.
The proposed research has social and scientific merit that is directed primarily toward improving the diagnosis, treatment, defining of risks, or prevention of cancer.
B.
All coinvestigators are qualified to undertake the proposed research by means of specific academic training or demonstrable, related experience in epidemiology, medical, biomedical, or statistical research.
C.
The hypotheses to be tested are explicit, and are determined to be researchable and feasible by the scientific peer review committee described in subpart 4.
D.
The methods proposed for testing the hypothesis clearly define:
(5)
the specific measurement techniques to be employed in analysis of data, including discussion of: major variables, statistical methods, methods of testing data reliability and validity, and required levels of accuracy, precision, or completeness of the data to be collected.
E.
The results of this study will be interpreted so that the findings can be used or generalized to other populations and provide a timely, substantive, and important contribution to the understanding of cancer diagnosis, treatment, or prevention in Minnesota.
Subp. 4.
Scientific peer review committee.
To assist in evaluating the scientific merits of proposals for research, the commissioner may appoint up to seven scientists to conduct scientific peer review who are qualified by having:
A.
attained the degree of medical doctor, doctor of science, doctor of philosophy, or equivalent degree from an accredited college or university;
B.
specific training in medicine, epidemiology, cancer research, or biometry from an accredited college or university; and
C.
two or more years of applied experience in epidemiology, medical research, biomedical research, or biometry.
History:
13 SR 528
Published Electronically:
May 12, 1997
4606.3308 CONTRACTS.
Subpart 1.
Contracts.
The commissioner may, upon receipt of an application described in this section, contract with any institution or reporting entity in compliance with part 4606.3304 for the following purposes:
A.
providing more efficient, expedient, and complete cancer registry and reporting systems for those required to report under part 4606.3303;
Subp. 2.
Notice of availability of funds.
The commissioner shall publish and distribute a notice of availability of funds and request for contract proposals to all hospitals, medical laboratories, tumor registries, and medical clinics required to report under part 4606.3303.
Subp. 3.
Content of application.
Applications made under this section shall address all of the following information requirements, including:
A.
Full corporate or company name, address, and tax identification number of applicant institution, or in the case of multiple institutions, the full corporate or company name, address, and tax identification number of the principal applicant institution, and the full corporate or company names and addresses of other institutions participating in the application.
B.
A description of the individual components of the reporting systems to be provided by the applicant. The quality assurance standards in part 4606.3305 shall be incorporated into all applications. For each component to be provided, the application must describe, but not be limited to:
(6)
a summary of the training and experience relevant to the components to be provided by the key personnel.
D.
Assurance that the privacy of all data will be maintained in accordance with law and acceptable medical practice.
Subp. 4.
Priority.
Priority will be given to applications proposing to provide cancer reporting systems addressing one or more of the following criteria:
History:
13 SR 528
Published Electronically:
May 12, 1997
4606.3309 CHARGES FOR DATA.
The commissioner may charge fees for out-of-pocket expenses including hourly employee wages, employee expenses, electronic data processing costs, duplicating, and clerical charges incurred as a result of requests by agencies for summary data compilation or analyses under the following conditions:
A.
the agency requesting the summary data is not a community health services agency as defined in Minnesota Statutes, chapter 145;
B.
the request requires more than one person hour of time to complete for an employee of the commissioner who is classified as either a programmer/analyst or higher, or an epidemiologist I or higher; and
C.
the estimated total out-of-pocket expenses, regardless of person hours needed to satisfy the request, are greater than $50.
History:
13 SR 528
Published Electronically:
May 12, 1997
Official Publication of the State of Minnesota
Revisor of Statutes